Anders Jack (CIK 1800668) reported 25 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-18). Recent activity: Sell RVMD (61 shares), Sell RVMD (3,992 shares), Buy RVMD (20,000 shares), Sell RVMD (4,553 shares), Sell RVMD (9,496 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-18 | Revolution Medicines, Inc. (RVMD) | Chief Financial Officer | Sell | 61 | $11,895 |
| 2026-09-18 | Revolution Medicines, Inc. (RVMD) | Chief Financial Officer | Sell | 3,992 | $795,618 |
| 2026-06-26 | Revolution Medicines, Inc. (RVMD) | Chief Financial Officer | Buy | 20,000 | $371,200 |
| 2026-06-26 | Revolution Medicines, Inc. (RVMD) | Chief Financial Officer | Sell | 4,553 | $761,945 |
| 2026-06-26 | Revolution Medicines, Inc. (RVMD) | Chief Financial Officer | Sell | 9,496 | $1.6M |
| 2026-06-26 | Revolution Medicines, Inc. (RVMD) | Chief Financial Officer | Sell | 5,651 | $956,375 |
| 2026-06-26 | Revolution Medicines, Inc. (RVMD) | Chief Financial Officer | Sell | 300 | $51,096 |
| 2026-06-18 | Revolution Medicines, Inc. (RVMD) | Chief Financial Officer | Sell | 2,722 | $424,959 |
| 2026-03-19 | Revolution Medicines, Inc. (RVMD) | Chief Financial Officer | Sell | 2,753 | $273,868 |
| 2026-03-03 | Revolution Medicines, Inc. (RVMD) | Chief Financial Officer | Buy | 20,200 | $0 |
| 2026-01-09 | Revolution Medicines, Inc. (RVMD) | Chief Financial Officer | Buy | 10,000 | $424,500 |
| 2026-01-09 | Revolution Medicines, Inc. (RVMD) | Chief Financial Officer | Sell | 10,000 | $980,000 |
| 2025-12-18 | Revolution Medicines, Inc. (RVMD) | Chief Financial Officer | Sell | 3,104 | $239,287 |
| 2025-11-26 | Revolution Medicines, Inc. (RVMD) | Chief Financial Officer | Buy | 5,418 | $92,106 |
| 2025-11-26 | Revolution Medicines, Inc. (RVMD) | Chief Financial Officer | Sell | 5,418 | $400,932 |
| 2025-11-13 | Revolution Medicines, Inc. (RVMD) | Chief Financial Officer | Buy | 10,000 | $170,000 |
| 2025-11-13 | Revolution Medicines, Inc. (RVMD) | Chief Financial Officer | Sell | 10,000 | $640,000 |
| 2025-09-18 | Revolution Medicines, Inc. (RVMD) | Chief Financial Officer | Sell | 2,320 | $106,302 |
| 2025-09-04 | Revolution Medicines, Inc. (RVMD) | Chief Financial Officer | Buy | 2,814 | $7,542 |
| 2025-09-04 | Revolution Medicines, Inc. (RVMD) | Chief Financial Officer | Buy | 1,948 | $9,214 |
| 2025-09-04 | Revolution Medicines, Inc. (RVMD) | Chief Financial Officer | Sell | 4,762 | $190,575 |
| 2025-09-04 | Revolution Medicines, Inc. (RVMD) | Chief Financial Officer | Buy | 3,189 | $15,084 |
| 2025-09-04 | Revolution Medicines, Inc. (RVMD) | Chief Financial Officer | Buy | 2,049 | $34,833 |
| 2025-09-04 | Revolution Medicines, Inc. (RVMD) | Chief Financial Officer | Sell | 5,238 | $210,410 |
| 2025-06-18 | Revolution Medicines, Inc. (RVMD) | Chief Financial Officer | Sell | 2,170 | $86,431 |
来源：SEC Form 4 申报文件 · 截至 2026-09-18